We have direct presence in Europe and Latin America
Almirall
Almirall around the world
Our medicines
Our aim is to improve people's health and wellbeing. We research, develop, produce and market our own R&D and licensed medicines.
This space is reserved for health professionals as it contains information on medicines.
Latest news
- 25/02/2010 Almirall: Solid performance in 2009, setting basis for sustainable long-term growth
- 24/02/2010 NEOGENIUS, the alliance between Almirall, Esteve, Palau Pharma and Proteomika, is to investigate ne...
- 12/02/2010 A multidisciplinary approach to improve treatment and reduce patient cardiovascular risk
- 08/02/2010 Silodosin, indicated for benign prostatic hyperplasia (BPH), has been approved by the European Comm...
Investors and shareholders
We offer the chance of developing a professional career within a sound and expanding company.
Optimized for Internet Explorer